Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.
European Journal of Medicinal Chemistry|November 18, 2022
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatizationMiriam Girardini, Francesca Ferlenghi, Giannamaria Annunziato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug toleranceHassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Microbiology Spectrum|November 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, et al.
Iscience|July 23, 2025
A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquilineZheng Yen Phua, Ming Li, Azhar Ali, et al.
The Journal of Biological Chemistry|January 4, 2024
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivoPriya Ragunathan, Patcharaporn Sae-Lao, Claire Hamela, et al.
Tuberculosis (Edinburgh, Scotland)|May 10, 2024
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendationsVéronique Dartois, Tracey L Bonfield, Jim P Boyce, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosisMekonnen Kurabachew, Stephen H J Lu, Philipp Krastel, et al.
Structure (London, England : 1993)|September 14, 2017
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2006
Peptide deformylase inhibitors as potent antimycobacterial agentsJeanette W P Teo, Pamela Thayalan, David Beer, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.
European Journal of Medicinal Chemistry|November 18, 2022
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatizationMiriam Girardini, Francesca Ferlenghi, Giannamaria Annunziato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug toleranceHassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Microbiology Spectrum|November 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, et al.
Iscience|July 23, 2025
A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquilineZheng Yen Phua, Ming Li, Azhar Ali, et al.
The Journal of Biological Chemistry|January 4, 2024
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivoPriya Ragunathan, Patcharaporn Sae-Lao, Claire Hamela, et al.
Tuberculosis (Edinburgh, Scotland)|May 10, 2024
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendationsVéronique Dartois, Tracey L Bonfield, Jim P Boyce, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosisMekonnen Kurabachew, Stephen H J Lu, Philipp Krastel, et al.
Structure (London, England : 1993)|September 14, 2017
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2006
Peptide deformylase inhibitors as potent antimycobacterial agentsJeanette W P Teo, Pamela Thayalan, David Beer, et al.
Pageof 18